Related Experiment Video
Updated: Aug 29, 2025

07:34
Microsurgical Venous Pouch Arterial-Bifurcation Aneurysms in the Rabbit Model: Technical Aspects
Published on: May 11, 2011
14.1K
Perioperative Bleeding Associated With Ibrutinib in Dermatologic Surgery: A Case-Control Study
Nessa Aghazadeh1, Mauricio F Jin2, Renee L Pride1
1Department of Dermatology, Mayo Clinic, Rochester, Minnesota.
Summary
Ibrutinib treatment increases bleeding risk during dermatologic surgery, especially in older men with low platelets. Consider temporarily stopping ibrutinib before skin procedures.
Area of Science:
- Oncology
- Dermatology
- Hematology
Background:
- Ibrutinib, a Bruton tyrosine kinase inhibitor, is linked to higher bleeding risks.
- Limited data exists on ibrutinib's bleeding risk during dermatologic surgery.
Purpose of the Study:
- To assess the frequency of bleeding complications in patients undergoing dermatologic surgery while on ibrutinib.
Main Methods:
- Retrospective, single-center, case-control study.
- Compared 37 patients on ibrutinib undergoing skin surgery with 64 matched controls.
- Data collected from January 2013 to March 2020.
Main Results:
- Ibrutinib use was associated with a significantly higher rate of bleeding events (8% vs 0.8%, p=0.02).
- Bleeding occurred more in older male patients with lower platelet counts.
- Patients experiencing bleeding were older (mean 82.7 vs 73.0 years) and had lower platelets (104.0 vs 150.5 K/μL).
Conclusions:
- Ibrutinib may increase bleeding risk in dermatologic surgery patients, particularly older men with low platelets.
- Transient discontinuation of ibrutinib may be advisable before dermatologic procedures.
Related Concept Videos
Inflammatory Bowel Disease V: Surgical Management
196
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
196
Skin Cancer
4.4K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.4K

